Placebo
Also known as: Placebo control, Sham treatment, Inactive control
Placebo is an inactive treatment or substance designed to resemble a real medication but containing no active therapeutic ingredient. Placebos are used in clinical trials as controls to measure the true effect of the drug being studied, accounting for psychological effects and natural disease fluctuation.
Last updated: January 21, 2026
Why Placebos Are Used
Placebos help distinguish between:
- Actual drug effects
- Placebo effect (psychological response)
- Natural disease variation
- Regression to the mean
Without placebo controls, it’s impossible to know if improvement is due to the drug.
The Placebo Effect
Real physiological changes can occur from expecting treatment:
| Condition | Placebo Response Rate |
|---|---|
| Pain | 20-40% improvement |
| Depression | 30-40% improvement |
| Nausea | 20-30% improvement |
| Weight loss | 1-3% in obesity trials |
These effects are real but not due to active medication.
Placebo Design in Trials
Matching
Placebos are designed to be indistinguishable:
- Same appearance (pill color, shape)
- Same packaging
- Same injection procedure (for injectable drugs)
- Same timing and frequency
Why Matching Matters
If participants can guess their assignment, this can:
- Inflate perceived effects in drug group
- Deflate perceived effects in placebo group
- Bias the study results
Placebo vs Active Comparator Trials
| Design | Control Group | Use Case |
|---|---|---|
| Placebo-controlled | Placebo | Establish any effect exists |
| Active comparator | Existing treatment | Compare to current standard |
| Placebo + standard care | Standard care alone | Test add-on therapy |
Placebo Results in Peptide Trials
Semaglutide Weight Loss Trials
| Group | Weight Loss |
|---|---|
| Semaglutide 2.4mg | -15% |
| Placebo | -2.4% |
| Drug attributable | ~12.6% |
The placebo group lost some weight from lifestyle modifications—the drug’s true effect is the difference.
Tirzepatide Trials
| Group | Weight Loss |
|---|---|
| Tirzepatide 15mg | -22.5% |
| Placebo | -2.4% |
| Drug attributable | ~20% |
Ethical Considerations
When Placebos Are Appropriate
- No proven effective treatment exists
- Condition is not life-threatening
- Short-term placebo unlikely to cause harm
- Participants give informed consent
When Placebos Are Problematic
- Effective treatment exists (use active comparator instead)
- Delaying treatment could cause serious harm
- Vulnerable populations without alternatives
Nocebo Effect
The opposite of placebo—negative expectations cause negative outcomes:
- Expecting side effects can produce them
- Can occur in both drug and placebo groups
- Explains some “side effects” in placebo groups
Frequently Asked Questions
Is the placebo effect “just in your head”?
No, placebo effects involve real physiological changes, including neurotransmitter release, immune function changes, and measurable brain activity. “Psychological” effects are biological—they’re just mediated by expectation rather than a drug.
Why do some people respond to placebo?
Placebo response varies by individual, condition, and context. Factors include: expectation of improvement, conditioning from past treatments, relationship with provider, and natural biological variation. Some conditions (pain, mood) are more placebo-responsive than others.
Is it ethical to use placebos in research?
Yes, when designed ethically. Participants must give informed consent knowing they might receive placebo. When effective treatments exist, new drugs are often compared to active treatment rather than placebo. Trials are reviewed by ethics boards to ensure patient safety.
Related Peptides
Related Terms
Disclaimer: This glossary entry is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for medical questions.